Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
Quality Of Care Varies Widely For Prostate Cancer, Study Says
Prostatectomy Improves Outcome In Some Men
Risk of Relapse Continues After Five Years of Therapy
Two Breast Cancer Screening Methods Found Equivalent
Zometa Prevents Bone Loss In Premenopausal Women
Risk Assessment Key In Long-Term Treatment
Survey Finds Misconceptions About Cancer Worldwide
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
- Survivorship begins at diagnosis—cancer care system must recognize this
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
